{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T12:20:11Z","timestamp":1790425211111,"version":"4.1.0"},"reference-count":124,"publisher":"Oxford University Press (OUP)","issue":"Supplement_1","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,2,28]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Respiratory viral infections (RVIs) are among the leading cause of morbidity and mortality in pediatric hematopoietic stem cell transplant (HCT) and solid organ transplant (SOT) recipients. Transplant recipients remain at high risk for super imposed bacterial and fungal pneumonia, chronic graft dysfunction, and graft failure as a result of RVIs. Recent multicenter retrospective studies and prospective studies utilizing contemporary molecular diagnostic techniques have better delineated the epidemiology and outcomes of RVIs in pediatric transplant recipients and have advanced the development of preventative vaccines and treatment interventions in this population. In this review, we will define the epidemiology and outcomes of RVIs in SOT and HSCT recipients, describe the available assays for diagnosing a suspected RVI, highlight evolving management and vaccination strategies, review the risk of donor derived RVI in SOT recipients, and discuss considerations for delaying transplantation in the presence of an RVI.<\/jats:p>","DOI":"10.1093\/jpids\/piad094","type":"journal-article","created":{"date-parts":[[2024,2,28]],"date-time":"2024-02-28T19:46:18Z","timestamp":1709149578000},"page":"S39-S48","source":"Crossref","is-referenced-by-count":12,"title":["Impact of Respiratory Viral Infections in Transplant Recipients"],"prefix":"10.1093","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9246-5662","authenticated-orcid":false,"given":"Hannah","family":"Bahakel","sequence":"first","affiliation":[{"name":"Division of Infectious Diseases, Cincinnati Children\u2019s Hospital Medical Center , Cincinnati, OH ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2268-9470","authenticated-orcid":false,"given":"Alpana","family":"Waghmare","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, University of Washington, Fred Hutchinson Cancer Research Center; Department of Infectious Diseases, Seattle Children\u2019s Hospital , Seattle, WA ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca Pellet","family":"Madan","sequence":"additional","affiliation":[{"name":"New York University Grossman School of Medicine; Department of Infectious Diseases, Hassenfeld Children\u2019s Hospital , New York, NY ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,2,28]]},"reference":[{"key":"2025052601263267800_CIT0001","doi-asserted-by":"crossref","first-page":"e13511","DOI":"10.1111\/ctr.13511","article-title":"RNA respiratory viral infections in solid organ transplant recipients: guidelines from the American Society of Transplantation Infectious Diseases Community of Practice","volume":"33","author":"Manuel","year":"2019","journal-title":"Clin Transplant"},{"key":"2025052601263267800_CIT0002","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1093\/jpids\/pix051","article-title":"A multicenter consortium to define the epidemiology and outcomes of inpatient respiratory viral infections in pediatric hematopoietic stem cell transplant recipients","volume":"7","author":"Fisher","year":"2017","journal-title":"J Pediatr Infect Dis Soc"},{"key":"2025052601263267800_CIT0003","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1034\/j.1399-3062.2001.003003138.x","article-title":"Community respiratory virus infections following lung transplantation","volume":"3","author":"Billings","year":"2001","journal-title":"Transpl Infect Dis"},{"key":"2025052601263267800_CIT0004","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1007\/s00467-011-1812-2","article-title":"Monitoring and managing viral infections in pediatric renal transplant recipients","volume":"27","author":"Comoli","year":"2012","journal-title":"Pediatr Nephrol (Berlin, Germany)"},{"key":"2025052601263267800_CIT0005","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1093\/jpids\/piy024","article-title":"A multicenter consortium to define the epidemiology and outcomes of pediatric solid organ transplant recipients with inpatient respiratory virus infection","volume":"8","author":"Danziger-Isakov","year":"2018","journal-title":"J Pediatr Infect Dis Soc"},{"key":"2025052601263267800_CIT0006","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1093\/cid\/ciad289","article-title":"Burden of respiratory viruses in children less than 2 years old in a community-based longitudinal US birth cohort","volume":"77","author":"Teoh","year":"2023","journal-title":"Clin Infect Dis"},{"key":"2025052601263267800_CIT0007","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1177\/135965350701200S06.1","article-title":"Respiratory viral infections in transplant recipients","volume":"12","author":"Ison","year":"2007","journal-title":"Antivir Ther"},{"key":"2025052601263267800_CIT0008","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.jcv.2012.06.019","article-title":"Diagnostic performance of two highly multiplexed respiratory virus assays in a pediatric cohort","volume":"55","author":"Forman","year":"2012","journal-title":"J Clin Virol"},{"key":"2025052601263267800_CIT0009","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1128\/CMR.00037-07","article-title":"Detection of respiratory viruses by molecular methods","volume":"21","author":"Mahony","year":"2008","journal-title":"Clin Microbiol Rev"},{"key":"2025052601263267800_CIT0010","first-page":"379","article-title":"Predictive value of respiratory viral detection in the upper respiratory tract for infection of the lower respiratory tract with hematopoietic stem cell transplantation","volume":"221","author":"Boonyaratanakornkit","year":"2020","journal-title":"J Infect Dis"},{"key":"2025052601263267800_CIT0011","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1111\/tid.12167","article-title":"Prolonged respiratory viral shedding in transplant patients","volume":"16","author":"de Lima","year":"2014","journal-title":"Transpl Infect Dis"},{"key":"2025052601263267800_CIT0012","doi-asserted-by":"crossref","first-page":"4160","DOI":"10.1128\/JCM.41.9.4160-4165.2003","article-title":"Comparison of quantitative reverse transcription-PCR to viral culture for assessment of respiratory syncytial virus shedding","volume":"41","author":"Falsey","year":"2003","journal-title":"J Clin Microbiol"},{"key":"2025052601263267800_CIT0013","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1111\/ajt.16357","article-title":"Clinical implications of SARS-CoV-2 cycle threshold values in solid organ transplant recipients","volume":"21","author":"Gaston","year":"2021","journal-title":"Am J Transpl"},{"key":"2025052601263267800_CIT0014","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1016\/j.transproceed.2021.01.035","article-title":"A less restrictive policy for liver transplantation in coronavirus disease 2019 positive patients, based upon cycle threshold values","volume":"53","author":"Raveh","year":"2021","journal-title":"Transplant Proc"},{"key":"2025052601263267800_CIT0015","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1097\/TP.0000000000003695","article-title":"Cycle thresholds among solid organ transplant recipients testing positive for SARS-CoV-2","volume":"105","author":"Theodore","year":"2021","journal-title":"Transplantation"},{"key":"2025052601263267800_CIT0016","doi-asserted-by":"crossref","first-page":"e01237","DOI":"10.1128\/JCM.01237-17","article-title":"Accurate PCR detection of Influenza A\/B and respiratory syncytial viruses by use of Cepheid Xpert Flu+ RSV Xpress Assay in point-of-care settings: comparison to Prodesse ProFlu+","volume":"56","author":"Cohen","year":"2018","journal-title":"J Clin Microbiol"},{"key":"2025052601263267800_CIT0017","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1128\/jcm.34.7.1649-1653.1996","article-title":"Rapid diagnosis of respiratory syncytial virus infections in immunocompromised adults","volume":"34","author":"Englund","year":"1996","journal-title":"J Clin Microbiol"},{"key":"2025052601263267800_CIT0018","doi-asserted-by":"crossref","first-page":"500","DOI":"10.7326\/0003-4819-156-7-201204030-00403","article-title":"Accuracy of rapid influenza diagnostic tests: a meta-analysis","volume":"156","author":"Chartrand","year":"2012","journal-title":"Ann Intern Med"},{"key":"2025052601263267800_CIT0019","doi-asserted-by":"crossref","first-page":"2611","DOI":"10.3389\/fmicb.2021.714242","article-title":"Factors that influence the reported sensitivity of rapid antigen testing for SARS-CoV-2","volume":"12","author":"Parvu","year":"2021","journal-title":"Front Microbiol"},{"key":"2025052601263267800_CIT0020","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1097\/MOT.0000000000000663","article-title":"Community acquired respiratory viruses in solid organ transplant","volume":"24","author":"Nam","year":"2019","journal-title":"Curr Opin Organ Transpl"},{"key":"2025052601263267800_CIT0021","first-page":"195","article-title":"The effects of the COVID-19 pandemic on community respiratory virus activity","volume":"21","author":"Chow","year":"2023","journal-title":"Nat Rev Microbiol"},{"key":"2025052601263267800_CIT0022","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1111\/j.1600-6143.2008.02278.x","article-title":"Respiratory failure associated with human metapneumovirus infection in an infant posthepatic transplant","volume":"8","author":"Evashuk","year":"2008","journal-title":"Am J Transplant"},{"key":"2025052601263267800_CIT0023","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1111\/petr.12022","article-title":"The impact of RSV, adenovirus, influenza, and parainfluenza infection in pediatric patients receiving stem cell transplant, solid organ transplant, or cancer chemotherapy","volume":"17","author":"Lo","year":"2013","journal-title":"Pediatr Transplant"},{"key":"2025052601263267800_CIT0024","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1111\/j.1399-3046.2008.01019.x","article-title":"Prospective study of infectious complications in a cohort of pediatric renal transplant recipients","volume":"13","author":"Mart\u00edn-Pe\u00f1a","year":"2009","journal-title":"Pediatr Transplant"},{"key":"2025052601263267800_CIT0025","doi-asserted-by":"crossref","first-page":"2331","DOI":"10.1007\/s00467-017-3737-x","article-title":"Infection-related hospitalizations after kidney transplantation in children: incidence, risk factors, and cost","volume":"32","author":"Hogan","year":"2017","journal-title":"Pediatric Nephrol (Berlin, Germany)"},{"key":"2025052601263267800_CIT0026","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/BF00862085","article-title":"Respiratory syncytial virus infections in pediatric renal transplant recipients","volume":"10","author":"Miller","year":"1996","journal-title":"Pediatric Nephrol (Berlin, Germany)"},{"key":"2025052601263267800_CIT0027","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1111\/j.1469-0691.2011.03537.x","article-title":"Pandemic influenza A (H1N1) virus infection in solid organ transplant recipients: impact of viral and non-viral co-infection","volume":"18","author":"Cordero","year":"2012","journal-title":"Clin Microbiol Infect"},{"key":"2025052601263267800_CIT0028","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.jpeds.2016.12.021","article-title":"Hospitalizations for respiratory syncytial virus and vaccine-preventable infections in the first 2 years after pediatric liver transplant","volume":"182","author":"Feldman","year":"2017","journal-title":"J Pediatr"},{"key":"2025052601263267800_CIT0029","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1111\/j.1399-3046.2006.00583.x","article-title":"Significant morbidity associated with RSV infection in immunosuppressed children following liver transplantation: case report and discussion regarding need of routine prophylaxis","volume":"10","author":"Blanchard","year":"2006","journal-title":"Pediatr Transplant"},{"key":"2025052601263267800_CIT0030","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1093\/infdis\/165.1.166","article-title":"Respiratory syncytial virus infections in pediatric liver transplant recipients","volume":"165","author":"Pohl","year":"1992","journal-title":"J Infect Dis"},{"key":"2025052601263267800_CIT0031","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1097\/MPG.0000000000003077","article-title":"Severe acute respiratory syndrome coronavirus-2 infection in children with liver transplant and native liver disease: an international observational registry study","volume":"72","author":"Kehar","year":"2021","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"2025052601263267800_CIT0032","doi-asserted-by":"crossref","first-page":"e13527","DOI":"10.1111\/ctr.13527","article-title":"Adenovirus in solid organ transplant recipients: guidelines from the American Society of Transplantation Infectious Diseases Community of Practice","volume":"33","author":"Florescu","year":"2019","journal-title":"Clin Transplant"},{"key":"2025052601263267800_CIT0033","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.jpeds.2021.05.025","article-title":"Hospitalizations for respiratory syncytial virus and vaccine preventable infections following pediatric heart transplantation","volume":"236","author":"Hayes","year":"2021","journal-title":"J Pediatr"},{"key":"2025052601263267800_CIT0034","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.healun.2021.11.003","article-title":"Early report from the Pediatric Heart Transplant Society on COVID-19 infections in pediatric heart transplant candidates and recipients","volume":"41","author":"Conway","year":"2022","journal-title":"J Heart Lung Transplant"},{"key":"2025052601263267800_CIT0035","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1111\/j.1399-3046.2010.01296.x","article-title":"Long-term impact of respiratory viral infection after pediatric lung transplantation","volume":"14","author":"Liu","year":"2010","journal-title":"Pediatr Transplant"},{"key":"2025052601263267800_CIT0036","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1164\/rccm.200310-1359OC","article-title":"Respiratory viral infections are a distinct risk for bronchiolitis obliterans syndrome and death","volume":"170","author":"Khalifah","year":"2004","journal-title":"Am J Respir Crit Care Med"},{"key":"2025052601263267800_CIT0037","doi-asserted-by":"crossref","first-page":"3284","DOI":"10.1111\/ajt.15505","article-title":"Absence of evidence that respiratory viral infections influence pediatric lung transplantation outcomes: results of the CTOTC-03 study","volume":"19","author":"Sweet","year":"2019","journal-title":"Am J Transplant"},{"key":"2025052601263267800_CIT0038","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/S0022-5223(98)70168-0","article-title":"Adenovirus infection in the lung results in graft failure after lung transplantation","volume":"116","author":"Bridges","year":"1998","journal-title":"J Thorac Cardiovasc Surg"},{"key":"2025052601263267800_CIT0039","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1111\/j.1399-3062.2009.00397.x","article-title":"Respiratory viral infections within one year after pediatric lung transplant","volume":"11","author":"Liu","year":"2009","journal-title":"Transplant Inf Dis"},{"key":"2025052601263267800_CIT0040","doi-asserted-by":"crossref","first-page":"e0257807","DOI":"10.1371\/journal.pone.0257807","article-title":"COVID-19 in lung transplant recipients\u2014Risk prediction and outcomes","volume":"16","author":"Kamp","year":"2021","journal-title":"PLoS One"},{"key":"2025052601263267800_CIT0041","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1097\/TP.0000000000003508","article-title":"COVID-19 in lung transplant recipients","volume":"105","author":"Messika","year":"2021","journal-title":"Transplantation"},{"key":"2025052601263267800_CIT0042","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1182\/bloodadvances.2018GS110686","article-title":"Working together: establishment of the first national hematopoietic stem cell transplantation (HSCT) center in Sri Lanka","volume":"2","author":"Abeysinghe","year":"2018","journal-title":"Blood Adv"},{"key":"2025052601263267800_CIT0043","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1097\/01.TP.0000072808.93060.0F","article-title":"Adenovirus infection in pediatric small bowel transplantation recipients","volume":"76","author":"Pinchoff","year":"2003","journal-title":"Transplantation"},{"key":"2025052601263267800_CIT0044","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1097\/TP.0b013e3181e0de97","article-title":"Adenovirus infections in pediatric small bowel transplant recipients","volume":"90","author":"Florescu","year":"2010","journal-title":"Transplantation"},{"key":"2025052601263267800_CIT0045","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1086\/322628","article-title":"Respiratory virus infections in pediatric hematopoietic stem cell transplantation","volume":"33","author":"Luj\u00e1n-Zilbermann","year":"2001","journal-title":"Clin Inf Dis"},{"key":"2025052601263267800_CIT0046","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1111\/j.1399-0012.2012.01607.x","article-title":"Respiratory viral infections during the first 28 days after transplantation in pediatric hematopoietic stem cell transplant recipients","volume":"26","author":"Lee","year":"2012","journal-title":"Clin Transplant"},{"key":"2025052601263267800_CIT0047","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1016\/j.bbmt.2015.06.015","article-title":"Significant transplantation-related mortality from respiratory virus infections within the first one hundred days in children after hematopoietic stem cell transplantation","volume":"21","author":"Hutspardol","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"key":"2025052601263267800_CIT0048","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1097\/01.inf.0000125161.33843.bb","article-title":"Prospective study of respiratory viral infections in pediatric hemopoietic stem cell transplantation patients","volume":"23","author":"Bredius","year":"2004","journal-title":"Pediatr Infect Dis J"},{"key":"2025052601263267800_CIT0049","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1093\/jpids\/pix051","article-title":"A multicenter consortium to define the epidemiology and outcomes of inpatient respiratory viral infections in pediatric hematopoietic stem cell transplant recipients","volume":"7","author":"Fisher","year":"2018","journal-title":"J Pediatr Infect Dis Soc"},{"key":"2025052601263267800_CIT0050","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1111\/tid.12116","article-title":"A multicenter evaluation of pandemic influenza A\/H1N1 in hematopoietic stem cell transplant recipients","volume":"15","author":"Reid","year":"2013","journal-title":"Transplant Inf Dis"},{"key":"2025052601263267800_CIT0051","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1111\/j.1600-6143.2011.03753.x","article-title":"Influenza vaccination in the organ transplant recipient: review and summary recommendations","volume":"11","author":"Kumar","year":"2011","journal-title":"Am J Transplant"},{"key":"2025052601263267800_CIT0052","first-page":"e13563","article-title":"AST ID community of practice vaccination of solid organ transplant candidates and recipients: guidelines from the American society of transplantation infectious diseases community of practice (vol 33, e13563, 2019)","volume":"34","author":"Danziger-Isakov","year":"2020","journal-title":"Clin Transplant"},{"key":"2025052601263267800_CIT0053","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr7101a1","article-title":"Prevention and control of seasonal influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices\u2014United States, 2022\u201323 influenza season","volume":"71","author":"Grohskopf","year":"2022","journal-title":"MMWR Recomm Rep"},{"key":"2025052601263267800_CIT0054","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1056\/NEJMc2210825","article-title":"Influenza vaccine in pediatric recipients of hematopoietic-cell transplants","volume":"388","author":"Schuster","year":"2023","journal-title":"N Engl J Med"},{"key":"2025052601263267800_CIT0055","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.bbmt.2015.12.003","article-title":"Randomized double-blind study of the safety and immunogenicity of standard-dose trivalent inactivated influenza vaccine versus high-dose trivalent inactivated influenza vaccine in adult hematopoietic stem cell transplantation patients","volume":"22","author":"Halasa","year":"2016","journal-title":"Biol Blood Marrow Transplant"},{"key":"2025052601263267800_CIT0056","doi-asserted-by":"crossref","first-page":"2204","DOI":"10.1001\/jama.2021.7489","article-title":"Antibody response to 2-dose SARS-CoV-2 mRNA vaccine series in solid organ transplant recipients","volume":"325","author":"Boyarsky","year":"2021","journal-title":"JAMA"},{"key":"2025052601263267800_CIT0057","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1038\/s41390-022-02374-4","article-title":"Humoral and cellular response to the COVID-19 vaccine in immunocompromised children","volume":"94","author":"Morgans","year":"2022","journal-title":"Pediatr Res"},{"key":"2025052601263267800_CIT0058","article-title":"US FDA approves GSK\u2019s RSV vaccine","author":"Foley"},{"key":"2025052601263267800_CIT0059","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.jpeds.2017.11.044","article-title":"Efficacy of a novel palivizumab prophylaxis protocol for respiratory syncytial virus infection in congenital heart disease: a multicenter study","volume":"195","author":"Chiu","year":"2018","journal-title":"J Pediatr"},{"key":"2025052601263267800_CIT0060","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1067\/S0022-3476(03)00454-2","article-title":"Palivizumab prophylaxis reduces hospitalization due to respiratory syncytial virus in young children with hemodynamically significant congenital heart disease","volume":"143","author":"Feltes","year":"2003","journal-title":"J Pediatr"},{"key":"2025052601263267800_CIT0061","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1046\/j.1440-1754.2002.00057.x","article-title":"Palivizumab prophylaxis of respiratory syncytial virus infection in high-risk infants","volume":"38","author":"Vogel","year":"2002","journal-title":"J Paediatr Child Health"},{"key":"2025052601263267800_CIT0062","doi-asserted-by":"crossref","first-page":"e44","DOI":"10.1093\/cid\/cit684","article-title":"2013 IDSA clinical practice guideline for vaccination of the immunocompromised host","volume":"58","author":"Rubin","year":"2014","journal-title":"Clin Inf Dis"},{"key":"2025052601263267800_CIT0063","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.1016\/j.bbmt.2016.07.005","article-title":"Restrictive palivizumab use does not lead to increased morbidity and mortality in pediatric hematopoietic stem cell transplantation patients","volume":"22","author":"Teusink-Cross","year":"2016","journal-title":"Biol Blood Marrow Transplant"},{"key":"2025052601263267800_CIT0064","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1111\/j.1399-3046.2008.01017.x","article-title":"Respiratory syncytial virus prophylaxis: a survey of pediatric solid organ transplant centers","volume":"13","author":"Michaels","year":"2009","journal-title":"Pediatr Transplant"},{"key":"2025052601263267800_CIT0065","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1111\/j.1399-3046.2012.01744.x","article-title":"RSV prevention and treatment in pediatric lung transplant patients: a survey of current practices among the International Pediatric Lung Transplant Collaborative","volume":"16","author":"Danziger-Isakov","year":"2012","journal-title":"Pediatr Transplant"},{"key":"2025052601263267800_CIT0066","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1056\/NEJMoa2110275","article-title":"Nirsevimab for prevention of RSV in healthy late-preterm and term infants","volume":"386","author":"Hammitt","year":"2022","journal-title":"N Engl J Med"},{"key":"2025052601263267800_CIT0067","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1056\/NEJMc2214773","article-title":"Nirsevimab for prevention of RSV in term and late-preterm infants","volume":"388","author":"Muller","year":"2023","journal-title":"N Engl J Med"},{"key":"2025052601263267800_CIT0068","doi-asserted-by":"crossref","first-page":"101965","DOI":"10.1016\/j.eclinm.2023.101965","article-title":"Vaccines and therapeutics for immunocompromised patients with COVID-19","volume":"59","author":"Shoham","year":"2023","journal-title":"Eclinicalmedicine"},{"key":"2025052601263267800_CIT0069","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.amjmed.2022.08.019","article-title":"The prevention of COVID-19 in high-risk patients using tixagevimab\u2013cilgavimab (Evusheld): real-world experience at a large academic center","volume":"136","author":"Al-Obaidi","year":"2023","journal-title":"Am J Med"},{"key":"2025052601263267800_CIT0070","doi-asserted-by":"crossref","first-page":"2188","DOI":"10.1056\/NEJMoa2116620","article-title":"Intramuscular AZD7442 (tixagevimab\u2013cilgavimab) for prevention of COVID-19","volume":"386","author":"Levin","year":"2022","journal-title":"N Engl J Med"},{"key":"2025052601263267800_CIT0071","doi-asserted-by":"crossref","first-page":"193","DOI":"10.3851\/IMP2058","article-title":"Antiviral therapies for respiratory viral infections in lung transplant patients","volume":"17","author":"Ison","year":"2012","journal-title":"Antivir Ther"},{"key":"2025052601263267800_CIT0072","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1017\/S1047951122002190","article-title":"Use of REGEN-COV in children after heart transplantation for treatment and post-exposure prophylaxis of COVID-19","volume":"33","author":"Gupta","year":"2023","journal-title":"Cardiol Young"},{"key":"2025052601263267800_CIT0073","doi-asserted-by":"crossref","first-page":"S344","DOI":"10.1093\/cid\/ciu623","article-title":"Management of respiratory viral infections in hematopoietic cell transplant recipients and patients with hematologic malignancies","volume":"59","author":"Chemaly","year":"2014","journal-title":"Clin Inf Dis"},{"key":"2025052601263267800_CIT0074","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1097\/INF.0b013e3182481ef8","article-title":"Characteristics and outcomes of pandemic 2009\/H1N1 versus seasonal influenza in children with cancer","volume":"31","author":"Shah","year":"2012","journal-title":"Pediatr Infect Dis J"},{"key":"2025052601263267800_CIT0075","doi-asserted-by":"crossref","first-page":"5050","DOI":"10.1182\/blood-2010-11-319186","article-title":"Differences in clinical outcomes after 2009 influenza A\/H1N1 and seasonal influenza among hematopoietic cell transplant recipients","volume":"117","author":"Choi","year":"2011","journal-title":"Blood"},{"key":"2025052601263267800_CIT0076","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1093\/cid\/ciy294","article-title":"A 5-year prospective multicenter evaluation of influenza infection in transplant recipients","volume":"67","author":"Kumar","year":"2018","journal-title":"Clin Inf Dis"},{"key":"2025052601263267800_CIT0077","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/S1473-3099(10)70133-X","article-title":"Outcomes from pandemic influenza A H1N1 infection in recipients of solid-organ transplants: a multicentre cohort study","volume":"10","author":"Kumar","year":"2010","journal-title":"Lancet Infect Dis"},{"key":"2025052601263267800_CIT0078","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1056\/NEJMoa1716197","article-title":"Baloxavir marboxil for uncomplicated influenza in adults and adolescents","volume":"379","author":"Hayden","year":"2018","journal-title":"N Engl J Med"},{"key":"2025052601263267800_CIT0079","doi-asserted-by":"crossref","first-page":"e13336","DOI":"10.1111\/tid.13336","article-title":"Baloxavir for the treatment of Influenza in allogeneic hematopoietic stem cell transplant recipients previously treated with oseltamivir","volume":"22","author":"Salvatore","year":"2020","journal-title":"Transplant Inf Dis"},{"key":"2025052601263267800_CIT0080","doi-asserted-by":"crossref","first-page":"104895","DOI":"10.1016\/j.micinf.2021.104895","article-title":"Combination of baloxavir and oseltamivir for treatment of severe influenza infection in hematopoietic cell transplant recipients: a novel treatment strategy for a high-risk population","volume":"24","author":"Angelidakis","year":"2022","journal-title":"Microbes Infect"},{"key":"2025052601263267800_CIT0081","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.ccm.2017.07.012","article-title":"Respiratory viral infections in solid organ and hematopoietic stem cell transplantation","volume":"38","author":"Paulsen","year":"2017","journal-title":"Clin Chest Med"},{"key":"2025052601263267800_CIT0082","doi-asserted-by":"crossref","first-page":"955","DOI":"10.3851\/IMP2192","article-title":"Efficacy and safety of oral oseltamivir for influenza prophylaxis in transplant recipients","volume":"17","author":"Ison","year":"2012","journal-title":"Antivir Ther"},{"key":"2025052601263267800_CIT0083","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/S1473-3099(11)70318-8","article-title":"Antiviral resistance during the 2009 influenza A H1N1 pandemic: public health, laboratory, and clinical perspectives","volume":"12","author":"Hurt","year":"2012","journal-title":"Lancet Infect Dis"},{"key":"2025052601263267800_CIT0084","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1007\/s12185-012-1139-1","article-title":"Outbreak of pandemic 2009 influenza A\/H1N1 infection in the hematology ward: fatal clinical outcome of hematopoietic stem cell transplant recipients and emergence of the H275Y neuraminidase mutation","volume":"96","author":"Iioka","year":"2012","journal-title":"Int J Hematol"},{"key":"2025052601263267800_CIT0085","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1111\/irv.12170","article-title":"Influenza prevention and treatment in transplant recipients and immunocompromised hosts","volume":"7","author":"Ison","year":"2013","journal-title":"Influenza Other Respir Viruses"},{"key":"2025052601263267800_CIT0086","doi-asserted-by":"crossref","first-page":"e13868","DOI":"10.1111\/petr.13868","article-title":"The pediatric solid organ transplant experience with COVID-19: an initial multi-center, multi-organ case series","volume":"25","author":"Goss","year":"2021","journal-title":"Pediatr Transplant"},{"key":"2025052601263267800_CIT0087","doi-asserted-by":"crossref","first-page":"e514","DOI":"10.1097\/INF.0000000000003293","article-title":"Clinical outcomes and antibody response in COVID-19\u2013positive pediatric solid organ transplant recipients","volume":"40","author":"Talgam-Horshi","year":"2021","journal-title":"Pediatr Infect Dis J"},{"key":"2025052601263267800_CIT0088","doi-asserted-by":"crossref","first-page":"2740","DOI":"10.1111\/ajt.16501","article-title":"COVID-19 in pediatric kidney transplantation: the improving renal outcomes collaborative","volume":"21","author":"Varnell Jr","year":"2021","journal-title":"Am J Transplant"},{"key":"2025052601263267800_CIT0089","volume-title":"The impact of COVID-19 on the pediatric solid organ transplant population. in Seminars in Pediatric Surgery","author":"Feldman","year":"2022"},{"key":"2025052601263267800_CIT0090","volume-title":"Coronavirus disease 2019 (COVID-19) treatment guidelines","author":"COVID-19 Treatment Guidelines Panel","year":"2023"},{"key":"2025052601263267800_CIT0091","author":"CDC-Remdesivir","year":"2023"},{"key":"2025052601263267800_CIT0092","year":"2022"},{"key":"2025052601263267800_CIT0093","doi-asserted-by":"crossref","first-page":"eabl7430","DOI":"10.1126\/scitranslmed.abl7430","article-title":"A phase 2a clinical trial of molnupiravir in patients with COVID-19 shows accelerated SARS-CoV-2 RNA clearance and elimination of infectious virus","volume":"14","author":"Fischer","year":"2021","journal-title":"Sci Transl Med"},{"key":"2025052601263267800_CIT0094","doi-asserted-by":"crossref","first-page":"2200","DOI":"10.1097\/TP.0000000000004306","article-title":"Preliminary clinical experience of molnupiravir to prevent progression of COVID-19 in kidney transplant recipients","volume":"106","author":"Villamar\u00edn","year":"2022","journal-title":"Transplantation"},{"key":"2025052601263267800_CIT0095","first-page":"7","article-title":"Ribavirin aerosol approved for severe cases of RSV in infants and young children","volume":"16","author":"Food and D Administration","year":"1986","journal-title":"FDA Drug Bull"},{"key":"2025052601263267800_CIT0096","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1093\/jac\/dkt111","article-title":"Impact of aerosolized ribavirin on mortality in 280 allogeneic haematopoietic stem cell transplant recipients with respiratory syncytial virus infections","volume":"68","author":"Shah","year":"2013","journal-title":"J Antimicrob Chemother"},{"key":"2025052601263267800_CIT0097","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.jhin.2016.11.012","article-title":"Effective use of oral ribavirin for respiratory syncytial viral infections in allogeneic haematopoietic stem cell transplant recipients","volume":"95","author":"Gorcea","year":"2017","journal-title":"J Hosp Infect"},{"key":"2025052601263267800_CIT0098","doi-asserted-by":"crossref","first-page":"e12844","DOI":"10.1111\/tid.12844","article-title":"Comparative effectiveness of aerosolized versus oral ribavirin for the treatment of respiratory syncytial virus infections: a single-center retrospective cohort study and review of the literature","volume":"20","author":"Trang","year":"2018","journal-title":"Transplant Inf Dis"},{"key":"2025052601263267800_CIT0099","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1016\/j.cmi.2023.04.021","article-title":"Ribavirin treatment for respiratory syncytial virus infection in patients with hematologic malignancy and hematopoietic stem cell transplant recipients: a systematic review and meta-analysis","volume":"29","author":"Manothummetha","year":"2023","journal-title":"Clin Microbiol Infect"},{"key":"2025052601263267800_CIT0100","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1038\/bmt.2016.124","article-title":"RSV infection without ribavirin treatment in pediatric hematopoietic stem cell transplantation","volume":"51","author":"El-Bietar","year":"2016","journal-title":"Bone Marrow Transplant"},{"key":"2025052601263267800_CIT0101","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/j.1399-3062.2009.00452.x","article-title":"Disseminated adenovirus infection in renal transplant recipients: the role of cidofovir and intravenous immunoglobulin","volume":"12","author":"Saquib","year":"2010","journal-title":"Transplant Inf Dis"},{"key":"2025052601263267800_CIT0102","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1097\/01.tp.0000209195.95115.8e","article-title":"Cidofovir for the treatment of adenoviral infection in pediatric hematopoietic stem cell transplant patients","volume":"81","author":"Yusuf","year":"2006","journal-title":"Transplantation"},{"key":"2025052601263267800_CIT0103","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1111\/j.1399-3046.2008.01014.x","article-title":"Adenovirus infection and treatment with cidofovir in children after liver transplantation","volume":"13","author":"Engelmann","year":"2009","journal-title":"Pediatr Transplant"},{"key":"2025052601263267800_CIT0104","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.healun.2007.06.009","article-title":"Treatment of adenovirus pneumonia with cidofovir in pediatric lung transplant recipients","volume":"26","author":"Doan","year":"2007","journal-title":"J Heart Lung Transplant"},{"key":"2025052601263267800_CIT0105","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1097\/00007890-200210150-00027","article-title":"Intravenous cidofovir therapy for disseminated adenovirus in a pediatric liver transplant recipient","volume":"74","author":"Carter","year":"2002","journal-title":"Transplantation"},{"key":"2025052601263267800_CIT0106","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1097\/TP.0000000000003988","article-title":"Adenovirus infection and transplantation","volume":"106","author":"Al-Heeti","year":"2022","journal-title":"Transplantation"},{"key":"2025052601263267800_CIT0107","doi-asserted-by":"crossref","first-page":"e13231","DOI":"10.1111\/petr.13231","article-title":"Virologic response with 2 different cidofovir dosing regimens for preemptive treatment of adenovirus DNAemia in pediatric solid organ transplant recipients","volume":"22","author":"Guerra Sanchez","year":"2018","journal-title":"Pediatr Transplant"},{"key":"2025052601263267800_CIT0108","doi-asserted-by":"crossref","first-page":"e467","DOI":"10.1097\/MPH.0000000000001480","article-title":"Brincidofovir as a salvage therapy in controlling adenoviremia in pediatric recipients of hematopoietic stem cell transplant","volume":"41","author":"Meena","year":"2019","journal-title":"J Pediatr Hematol Oncol"},{"key":"2025052601263267800_CIT0109","doi-asserted-by":"crossref","first-page":"e13769","DOI":"10.1111\/petr.13769","article-title":"Brincidofovir for the treatment of human adenovirus infection in pediatric solid organ transplant recipients: a case series","volume":"24","author":"Londeree","year":"2020","journal-title":"Pediatr Transplant"},{"key":"2025052601263267800_CIT0110","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.jcv.2017.09.013","article-title":"Disseminated adenovirus infection after allogeneic stem cell transplant and the potential role of brincidofovir \u2013 case series and 10 year experience of management in an adult transplant cohort","volume":"96","author":"Ramsay","year":"2017","journal-title":"J Clin Virol"},{"key":"2025052601263267800_CIT0111","volume-title":"PLACEHOLDER for"},{"key":"2025052601263267800_CIT0112","doi-asserted-by":"crossref","first-page":"e100462","DOI":"10.5812\/archcid.100462","article-title":", Successful treatment of severe parainfluenza pneumonia in a liver transplant recipient with oral ribavirin and intravenous immunoglobulin","volume":"15","author":"Ghiasvand","year":"2020","journal-title":"Arch Clin Infect Dis"},{"key":"2025052601263267800_CIT0113","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1111\/ajt.16178","article-title":"Ten years of donor-derived disease: a report of the disease transmission advisory committee","volume":"21","author":"Kaul","year":"2021","journal-title":"Am J Transplant"},{"key":"2025052601263267800_CIT0114","author":"Transplantation, A.S.f","year":"2023"},{"key":"2025052601263267800_CIT0115","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1111\/j.1399-3062.2006.00175.x","article-title":"Influenza transmission to recipient through lung transplantation","volume":"9","author":"Meylan","year":"2007","journal-title":"Transpl Infect Dis"},{"key":"2025052601263267800_CIT0116","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1097\/TP.0b013e3181da1933","article-title":"Influenza B virus transmission in recipients of kidney and lung transplants from an infected donor","volume":"90","author":"Le Page","year":"2010","journal-title":"Transplantation"},{"key":"2025052601263267800_CIT0117","doi-asserted-by":"crossref","first-page":"e107","DOI":"10.1111\/j.1432-2277.2011.01342.x","article-title":"Transplantation of solid organs procured from influenza A H1N1 infected donors","volume":"24","author":"Cockbain","year":"2011","journal-title":"Transpl Int"},{"key":"2025052601263267800_CIT0118","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1097\/TP.0b013e3182445e71","article-title":"Risk of transmission of H1N1 influenza by solid organ transplantation in the United Kingdom","volume":"93","author":"Halliday","year":"2012","journal-title":"Transplantation"},{"key":"2025052601263267800_CIT0119","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1111\/j.1600-6143.2009.02960.x","article-title":"Guidance on novel influenza A\/H1N1 in solid organ transplant recipients","volume":"10","author":"Kumar","year":"2010","journal-title":"Am J Transplant"},{"key":"2025052601263267800_CIT0120","doi-asserted-by":"crossref","first-page":"4411","DOI":"10.1016\/j.transproceed.2009.09.052","article-title":"Postexposure prophylaxis of H1N1 with oseltamivir in a newly transplanted kidney recipient receiving intense immunosuppressive therapy","volume":"41","author":"Marfo","year":"2009","journal-title":"Transplant Proc"},{"key":"2025052601263267800_CIT0121","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1111\/j.1399-3062.2010.00494.x","article-title":"Pandemic influenza A\/H1N1 and organ donation","volume":"12","author":"Lattes","year":"2010","journal-title":"Transplant Inf Dis"},{"key":"2025052601263267800_CIT0122","doi-asserted-by":"crossref","first-page":"e13375","DOI":"10.1111\/petr.13375","article-title":"Infections among pediatric transplant candidates: an approach to decision-making","volume":"23","author":"L\u2019Huillier","year":"2019","journal-title":"Pediatr Transplant"},{"key":"2025052601263267800_CIT0123","doi-asserted-by":"crossref","first-page":"2682","DOI":"10.1182\/blood-2016-01-634873","article-title":"How I treat respiratory viral infections in the setting of intensive chemotherapy or hematopoietic cell transplantation","volume":"127","author":"Waghmare","year":"2016","journal-title":"Blood"},{"key":"2025052601263267800_CIT0124","doi-asserted-by":"crossref","first-page":"5307","DOI":"10.1182\/bloodadvances.2021004915","article-title":"Respiratory viruses in hematopoietic cell transplant candidates: impact of preexisting lower tract disease on outcomes","volume":"6","author":"Kim","year":"2022","journal-title":"Blood Adv"}],"container-title":["Journal of the Pediatric Infectious Diseases Society"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jpids\/article-pdf\/13\/Supplement_1\/S39\/56778772\/piad094.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jpids\/article-pdf\/13\/Supplement_1\/S39\/56778772\/piad094.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,26]],"date-time":"2025-05-26T05:26:54Z","timestamp":1748237214000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jpids\/article\/13\/Supplement_1\/S39\/7615743"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,1]]},"references-count":124,"journal-issue":{"issue":"Supplement_1","published-print":{"date-parts":[[2024,2,28]]}},"URL":"https:\/\/doi.org\/10.1093\/jpids\/piad094","relation":{},"ISSN":["2048-7207"],"issn-type":[{"value":"2048-7207","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,2,1]]},"published":{"date-parts":[[2024,2,1]]}}}